Updated daily
View our work on COVID-19 vaccinations
Statistics and Research

Coronavirus (COVID-19) Vaccinations

Our international COVID-19 vaccination dataset is updated each morning (London time), with data up to the previous day.
Reuse our work freelyCite this research

Our vaccination dataset uses the most recent official numbers from governments and health ministries worldwide. Population estimates for per-capita metrics are based on the United Nations World Population Prospects. Income groups are based on the World Bank classification. A full list of our country-specific sources is available at the bottom of this page, and we also answer frequently-asked questions there.

In our Data Explorer you can see all of our data on COVID-19 vaccinations (doses administered, people with at least 1 dose, and people fully vaccinated).

Open the Data Explorer in a new tab.

Select a group of countries at once: all European countries, 30 largest countries; EU; Americas; OECD.


The Our World in Data COVID vaccination data

To bring this pandemic to an end, a large share of the world needs to be immune to the virus. The safest way to achieve this is with a vaccine. Vaccines are a technology that humanity has often relied on in the past to bring down the death toll of infectious diseases.

Within less than 12 months after the beginning of the COVID-19 pandemic, several research teams rose to the challenge and developed vaccines that protect from SARS-CoV-2, the virus that causes COVID-19.

Now the challenge is to make these vaccines available to people around the world. It will be key that people in all countries — not just in rich countries — receive the required protection. To track this effort we at Our World in Data are building the international COVID-19 vaccination dataset that we make available on this page. It is updated each morning, with the most recent official numbers up to the previous day.

  • Open access: as with all of our data, we are making this dataset openly available, so that everyone can check and use the data that we bring together. You find the vaccination data in our daily-updated repository on GitHub.
Our work belongs to everyone
Cite our vaccination data
Mathieu, E., Ritchie, H., Ortiz-Ospina, E. et al. A global database of COVID-19 vaccinations. Nat Hum Behav (2021)

Country-by-country data on COVID-19 vaccinations

This page has a number of charts on vaccination. In the box below you can select any country you are interested in — or several, if you want to compare countries.

All charts on this page will then show data for the countries that you selected.

None selected

What share of the population has been partly or fully vaccinated against COVID-19?

The following charts show the breakdown of vaccinations by those that have been partly or fully vaccinated. A person is considered partly vaccinated if they have received only one dose of a 2-dose vaccine protocol. A person is considered fully vaccinated if they have received a single-dose vaccine or both doses of a two-dose vaccine.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

How many COVID-19 vaccine doses are administered daily?

Daily number of COVID-19 vaccinations administered per 100 people

The following chart shows the daily number of COVID-19 vaccination doses administered per 100 people. This is shown as the rolling seven-day average. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

Daily number of COVID-19 vaccinations administered

How many COVID-19 vaccination doses have been administered?

The following map and chart show the number of COVID-19 vaccination doses administered per 100 people within a given population. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime, as several available COVID vaccines require multiple doses.

Total number of COVID-19 vaccinations administered

The following chart shows the total number of COVID-19 vaccination doses administered. Note that this is counted as a single dose, and may not equal the total number of people vaccinated, depending on the specific dose regime (e.g. people receive multiple doses).

What share of the population has received at least one dose of the COVID-19 vaccine?

The following chart shows the share of the total population that has received at least one dose of the COVID-19 vaccine. This may not equal the share that are fully vaccinated if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

Total number of people who have received at least one dose of the COVID-19 vaccine

The following chart shows the total number of people that have received at least one dose of the COVID-19 vaccine. This may not equal the number that are fully vaccinated if the vaccine requires two doses. If a person receives the first dose of a 2-dose vaccine, this metric goes up by 1. If they receive the second dose, the metric stays the same.

What share of the population has been fully vaccinated against COVID-19?

The following chart shows the share of the total population that has been fully vaccinated against COVID-19. This represents the share that have received all doses prescribed by the vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

Total number of people who have been fully vaccinated against COVID-19

The following chart shows the total number of people that have been fully vaccinated against COVID-19. This represents the number that have received all doses prescribed by the vaccination protocol. If a person receives the first dose of a 2-dose vaccine, this metric stays the same. If they receive the second dose, the metric goes up by 1.

This data is only available for countries which report the breakdown of doses administered by first and second doses.

How many vaccine booster doses have been administered?

The following charts show the number of booster doses administered. Booster doses are doses administered beyond those prescribed by the original vaccination protocol — for example, a third dose of Pfizer/BioNTech vaccine, or a second dose of Johnson & Johnson vaccine.

Vaccinations by age

The following charts provide data on the share of people that have been vaccinated against COVID-19 by age group. This is provided as three metrics: the share that have received at least one dose; the share that have been fully vaccinated; and the share that are only partly vaccinated.

Some of this data is only available for countries which report the breakdown of doses administered by first and second doses by age.

Share that have received at least one dose by age

The following chart shows the share of the population in each age group that have received at least one dose of the COVID-19 vaccine. This metric includes those that are either partly or fully vaccinated.

Fully vaccinated by age

The following chart shows the share of the population in each age group that are fully vaccinated against COVID-19. This represents the share that have received all doses prescribed by the vaccination protocol.

Share that have received a booster dose by age

The following chart shows the share of the population in each age group that has received a booster dose against COVID-19.

Which vaccines have been administered in each country?

The following chart shows the cumulative number of doses administered, broken down by vaccine manufacturer. This is only available for a select number of countries which report the necessary data.

How many doses have been donated by each country?

These charts show the cumulative number of doses donated to the COVAX initiative by different countries, broken down by whether the donations have only been announced, actually donated, or delivered to the recipients. This is only available for a select number of countries for which the COVID-19 Task Force reports the necessary data.

The three following charts show the number of doses donated, adjusted for:

  1. The population of the donating country;
  2. The GDP of the donating country;
  3. The number of doses administered by the donating country to its own population.

COVID-19 Vaccines Global Access (COVAX)

COVAX is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO). COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines.

Vaccination policies

This interactive chart maps government policies on COVID-19 vaccination. Note that this only tracks policies on the availability of vaccinations. It does not track the number of people who have been vaccinated.

Countries are grouped into six categories:

  • No availability
  • Availability for ONE of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for TWO of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for ALL of following: key workers/ clinically vulnerable groups / elderly groups
  • Availability for all three plus partial additional availability (select broad groups/ages)
  • Universal availability

Vaccination policy data is sourced from the Oxford Coronavirus Government Response Tracker

This data on vaccination policies is sourced from the Oxford Coronavirus Government Response Tracker (OxCGRT).

This resource is published by researchers at the Blavatnik School of Government at the University of Oxford: Thomas Hale, Anna Petherik, Beatriz Kira, Noam Angrist, Toby Phillips and Samuel Webster.

The tracker presents data collected from public sources by a team of over one hundred Oxford University students and staff from every part of the world.

The data presented here is taken directly from the OxCGRT project; Our World in Data do not track policy responses ourselves, and do not make additions to the tracker dataset.

These charts are regularly updated based on the latest version of the response tracker.

OxCGRT is an ongoing collation project of live data. If you see any inaccuracies in the underlying data, or for specific feedback on the analysis or another aspect of the project please contact OxCGRT team. See the tracker’s notes and guidance on data quality.

Attitudes to COVID-19 vaccinations

The Imperial College London YouGov Covid-19 Behaviour Tracker Data Hub gathers global insights on people’s behaviors in response to COVID-19. This survey covers public behaviors and attitudes ranging from mask-wearing to self-isolation, social distancing, symptoms and testing.

The following two charts show monthly data from this survey on the willingness of people to get vaccinated against COVID-19. Survey respondents were presented with the following statement: “If a COVID-19 vaccine were made available to me this week, I would definitely get it.” Respondents were asked to react to this statement on a 1 to 5 scale, ranging from “Strongly agree” (1) to “Strongly disagree” (5).

Based on this scale, we consider respondents to be willing to get a COVID-19 vaccine if they selected 1 or 2, unwilling to get a COVID-19 vaccine if they selected 4 or 5, and uncertain if they are willing to get a COVID-19 vaccine if they selected 3.

Both charts below show the share of a country’s population that has received at least one dose of a COVID-19 vaccine in comparison to the share of the population that is unvaccinated, where the share of the unvaccinated population is separated into those who would be willing vs. unwilling vs. uncertain if they would get a COVID-19 vaccine if it was made available to them this week.1

The first chart shows this data for a single country over time, while the second chart shows the same data for multiple countries at a single point in time.

Vaccine development: vaccines approved for use and in clinical trials

The speed at which the first COVID-19 vaccines were developed was extraordinary. We have previously looked into the history of vaccine development. The measles vaccine was found relatively rapidly: it took only 10 years from the discovery of the pathogen to the development of the first vaccine. But for typhoid it took more than a century, and for some diseases for which we’ve known the pathogens for more than a century (like malaria) we still haven’t found an effective vaccine.

The development of a vaccine against COVID-19 has been much faster than the development of any other vaccine. Within less than a year several successful vaccines have already been announced and were approved for use in some countries. 

The hope is that even more manufacturers develop vaccines for COVID-19. This will be important because eventually a very large share of the world population needs to receive a COVID-19 vaccine.

We are on the way to several vaccines against COVID-19 – vaccine trackers monitor the progress:

Several institutions maintain websites on which they list COVID-19 candidate vaccines that are currently being developed:

Source information country by country

You can download the full dataset alongside the detailed sources on GitHub.

Vaccination against COVID-19 has now started in 218 locations.

LocationSourceLast observation dateVaccines
AfghanistanWorld Health OrganizationNov. 27, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
AlbaniaMinistry of HealthDec. 3, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
AlgeriaWorld Health OrganizationNov. 29, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V
AndorraWorld Health OrganizationOct. 31, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
AngolaWorld Health OrganizationDec. 2, 2021Oxford/AstraZeneca
AnguillaWorld Health OrganizationDec. 1, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Antigua and BarbudaMinistry of HealthNov. 26, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
ArgentinaMinistry of HealthDec. 5, 2021CanSino, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
ArmeniaWorld Health OrganizationNov. 28, 2021Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V
ArubaGovernment of ArubaDec. 3, 2021Pfizer/BioNTech
AustraliaGovernment of Australia via CovidBaseAUDec. 5, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
AustriaMinistry of HealthDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
AzerbaijanGovernment of AzerbaijanDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
BahamasPan American Health OrganizationNov. 29, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech
BahrainMinistry of HealthDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
BangladeshDirectorate General of Health ServicesDec. 5, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BarbadosMinistry of HealthDec. 4, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BelarusWorld Health OrganizationNov. 28, 2021Sinopharm/Beijing, Sputnik V
BelgiumSciensanoDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
BelizeWorld Health OrganizationDec. 3, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BeninMinistry of HealthNov. 19, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
BermudaPan American Health OrganizationNov. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech
BhutanWorld Health OrganizationNov. 28, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
BoliviaMinistry of Health via https://www.boligrafica.com/Dec. 2, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
Bonaire Sint Eustatius and SabaWorld Health OrganizationSep. 1, 2021Moderna, Pfizer/BioNTech
Bosnia and HerzegovinaPublic Health InstituteNov. 4, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
BotswanaAfrica Centres for Disease Control and PreventionDec. 2, 2021Covaxin, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
BrazilState governments via coronavirusbra1.github.ioDec. 5, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
British Virgin IslandsWorld Health OrganizationDec. 3, 2021Johnson&Johnson, Oxford/AstraZeneca
BruneiMinistry of HealthDec. 5, 2021Oxford/AstraZeneca, Sinopharm/Beijing
BulgariaMinistry of HealthDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Burkina FasoWorld Health OrganizationNov. 4, 2021Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
BurundiWorld Health OrganizationDec. 1, 2021Sinopharm/Beijing
CambodiaMinistry of HealthDec. 2, 2021Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
CameroonWorld Health OrganizationNov. 29, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
CanadaOfficial data from provinces via covid19tracker.caDec. 5, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Cape VerdeWorld Health OrganizationNov. 26, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
Cayman IslandsWorld Health OrganizationDec. 3, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Central African RepublicAfrica Centres for Disease Control and PreventionNov. 19, 2021Covaxin, Oxford/AstraZeneca
ChadAfrica Centres for Disease Control and PreventionNov. 27, 2021Sinopharm/Beijing
ChileMinisterio de Ciencia, Tecnología, Conocimiento e InnovaciónDec. 4, 2021CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
ChinaNational Health CommissionDec. 5, 2021CanSino, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac, ZF2001
ColombiaMinistry of HealthDec. 3, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
ComorosWorld Health OrganizationNov. 28, 2021Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing
CongoAfrica Centres for Disease Control and PreventionDec. 2, 2021Moderna, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Cook IslandsSPC Public Health DivisionNov. 8, 2021Pfizer/BioNTech
Costa RicaCosta Rican Social Security FundNov. 29, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Cote d’IvoireWorld Health OrganizationNov. 14, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
CroatiaMinistry of HealthDec. 4, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CubaMinistry of HealthDec. 3, 2021Abdala, Soberana02
CuracaoGovernment of CuracaoDec. 4, 2021Moderna, Pfizer/BioNTech
CyprusMinistry of HealthDec. 1, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
CzechiaMinistry of HealthDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Democratic Republic of CongoWorld Health OrganizationNov. 29, 2021Oxford/AstraZeneca
DenmarkStatens Serum InstituteDec. 2, 2021Johnson&Johnson, Moderna, Pfizer/BioNTech
DjiboutiWorld Health OrganizationDec. 2, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
DominicaPan American Health OrganizationDec. 3, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
Dominican RepublicMinistry of Public HealthDec. 4, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
EcuadorGovernment of Ecuador via EcuacovidDec. 1, 2021CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
EgyptWorld Health OrganizationNov. 29, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
El SalvadorMinistry of HealthDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
EnglandGovernment of the United KingdomDec. 4, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Equatorial GuineaMinistry of HealthDec. 1, 2021Sinopharm/Beijing
EstoniaNational Health BoardDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
EswatiniWorld Health OrganizationNov. 24, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech
EthiopiaMinistry of HealthDec. 5, 2021Oxford/AstraZeneca
Faeroe IslandsGovernment of the Faeroe IslandsNov. 5, 2021Moderna, Pfizer/BioNTech
Falkland IslandsGovernment of the Falkland IslandsApr. 14, 2021Oxford/AstraZeneca
FijiSPC Public Health DivisionNov. 30, 2021Oxford/AstraZeneca
FinlandFinnish Institute for Health and WelfareDec. 4, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
FrancePublic Health FranceDec. 2, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
French PolynesiaSPC Public Health DivisionNov. 30, 2021Johnson&Johnson, Pfizer/BioNTech
GabonAfrica Centres for Disease Control and PreventionNov. 24, 2021Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
GambiaAfrica Centres for Disease Control and PreventionNov. 21, 2021Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
GeorgiaNational Center for Disease Control and Public HealthDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
GermanyRobert Koch InstitutDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GhanaWorld Health OrganizationNov. 24, 2021Oxford/AstraZeneca, Sputnik V
GibraltarGovernment of GibraltarDec. 4, 2021Pfizer/BioNTech
GreeceMinistry of HealthDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GreenlandGovernment of GreenlandDec. 3, 2021Moderna
GrenadaWorld Health OrganizationDec. 3, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech
GuatemalaMinistry of HealthDec. 4, 2021Moderna, Oxford/AstraZeneca
GuernseyGovernment of GuernseyNov. 22, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
GuineaNational Health Security AgencyDec. 4, 2021Sputnik V
Guinea-BissauWorld Health OrganizationNov. 28, 2021Oxford/AstraZeneca, Sinopharm/Beijing
GuyanaMinistry of HealthDec. 2, 2021Oxford/AstraZeneca, Sputnik V
HaitiPan American Health OrganizationNov. 19, 2021Johnson&Johnson, Moderna
HondurasWorld Health OrganizationNov. 29, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
Hong KongGovernment of Hong KongDec. 5, 2021Pfizer/BioNTech, Sinovac
HungaryGovernment of HungaryDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
IcelandDirectorate of HealthDec. 2, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
IndiaGovernment of IndiaDec. 5, 2021Covaxin, Oxford/AstraZeneca, Sputnik V
IndonesiaGovernment of IndonesiaDec. 4, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
IranWorld Health OrganizationDec. 5, 2021COVIran Barekat, Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing, Soberana02, Sputnik V
IraqWorld Health OrganizationNov. 30, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
IrelandHeath Service ExecutiveDec. 2, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Isle of ManIsle of Man GovernmentDec. 4, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Israel (see FAQ)Government of IsraelDec. 5, 2021Moderna, Pfizer/BioNTech
ItalyExtraordinary commissioner for the Covid-19 emergencyDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JamaicaMinistry of HealthDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JapanPrime Minister’s OfficeDec. 5, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JerseyGovernment of JerseyDec. 2, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
JordanGovernment of JordanDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
KazakhstanGovernment of KazakhstanDec. 5, 2021QazVac, Sinopharm/Beijing, Sputnik V
KenyaMinistry of HealthDec. 5, 2021Oxford/AstraZeneca, Sputnik V
KiribatiSPC Public Health DivisionNov. 30, 2021Oxford/AstraZeneca
KosovoMinistry of HealthDec. 4, 2021Oxford/AstraZeneca, Pfizer/BioNTech
KuwaitWorld Health OrganizationNov. 30, 2021Pfizer/BioNTech
KyrgyzstanMinistry of HealthDec. 5, 2021Sinopharm/Beijing, Sputnik V
LaosWorld Health OrganizationNov. 23, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
LatviaNational Health ServiceDec. 5, 2021Johnson&Johnson, Moderna, Pfizer/BioNTech
LebanonGovernment of LebanonDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
LesothoWorld Health OrganizationNov. 17, 2021Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
LiberiaWorld Health OrganizationNov. 18, 2021Oxford/AstraZeneca
LibyaWorld Health OrganizationDec. 2, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
LiechtensteinFederal Office of Public HealthDec. 2, 2021Moderna, Pfizer/BioNTech
LithuaniaMinistry of HealthDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
LuxembourgGovernment of LuxembourgNov. 29, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MacaoGovernment of MacaoDec. 5, 2021Pfizer/BioNTech, Sinopharm/Beijing
MadagascarWorld Health OrganizationNov. 29, 2021Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
MalawiMinistry of HealthDec. 5, 2021Johnson&Johnson, Oxford/AstraZeneca
MalaysiaGovernment of MalaysiaDec. 3, 2021CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
MaldivesPresidency of the MaldivesDec. 4, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
MaliWorld Health OrganizationNov. 28, 2021Oxford/AstraZeneca
MaltaCOVID-19 Malta Public Health Response TeamDec. 4, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
MauritaniaAfrica Centres for Disease Control and PreventionDec. 2, 2021Oxford/AstraZeneca, Sinopharm/Beijing
MauritiusWorld Health OrganizationNov. 23, 2021Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing
MexicoSecretary of HealthDec. 5, 2021CanSino, Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
MoldovaMinistry of HealthDec. 4, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MonacoNational CouncilSep. 16, 2021Pfizer/BioNTech
MongoliaMinistry of Health via ikon.mnDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MontenegroGovernment of MontenegroDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MontserratWorld Health OrganizationNov. 12, 2021Oxford/AstraZeneca
MoroccoWorld Health OrganizationNov. 29, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
MozambiqueWorld Health OrganizationDec. 2, 2021Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
MyanmarWorld Health OrganizationNov. 27, 2021Oxford/AstraZeneca, Sinopharm/Beijing
NamibiaAfrica Centres for Disease Control and PreventionDec. 2, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
NauruWorld Health OrganizationAug. 31, 2021Oxford/AstraZeneca
NepalWorld Health OrganizationNov. 29, 2021Covaxin, Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
NetherlandsGovernment of the NetherlandsDec. 1, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
New CaledoniaSPC Public Health DivisionNov. 30, 2021Pfizer/BioNTech
New ZealandMinistry of HealthDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech
NicaraguaWorld Health OrganizationDec. 1, 2021Abdala, Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Soberana02, Sputnik Light, Sputnik V
NigerWorld Health OrganizationNov. 28, 2021Oxford/AstraZeneca, Sinopharm/Beijing
NigeriaWorld Health OrganizationDec. 2, 2021Oxford/AstraZeneca
NiueSPC Public Health DivisionAug. 2, 2021Oxford/AstraZeneca
North MacedoniaGovernment of North MacedoniaNov. 22, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
Northern CyprusMinistry of HealthNov. 26, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
Northern IrelandGovernment of the United KingdomDec. 4, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
NorwayNorwegian Institute of Public HealthDec. 2, 2021Moderna, Pfizer/BioNTech
OmanWorld Health OrganizationNov. 23, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
PakistanNational Command and Operation CentreDec. 5, 2021CanSino, Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
Palestine (see FAQ)World Health OrganizationNov. 22, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
PanamaPan American Health OrganizationDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Papua New GuineaSPC Public Health DivisionNov. 30, 2021Oxford/AstraZeneca
ParaguayPan American Health OrganizationDec. 3, 2021Covaxin, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
PeruMinisterio de Salud via github.com/jmcastagnetto/covid-19-peru-vacunasDec. 1, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
PhilippinesDepartment of Health via ABS-CBN Investigative and Research GroupDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
PitcairnSPC Public Health DivisionSep. 7, 2021Oxford/AstraZeneca
PolandMinistry of HealthDec. 4, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
PortugalDirectorate General for Health via Data Science for Social GoodDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
QatarMinistry of Public HealthDec. 4, 2021Moderna, Pfizer/BioNTech
RomaniaGovernment of Romania via datelazi.roDec. 4, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
RussiaOfficial data from local governments via gogov.ruDec. 5, 2021EpiVacCorona, Sputnik V
RwandaWorld Health OrganizationDec. 2, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
Saint HelenaGovernment of Saint HelenaMay. 5, 2021Oxford/AstraZeneca
Saint Kitts and NevisPan American Health OrganizationDec. 3, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Saint LuciaMinistry of HealthDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Saint Vincent and the GrenadinesMinistry of HealthDec. 5, 2021Oxford/AstraZeneca
SamoaSPC Public Health DivisionNov. 30, 2021Oxford/AstraZeneca
San MarinoWorld Health OrganizationNov. 28, 2021Pfizer/BioNTech, Sputnik V
Sao Tome and PrincipeWorld Health OrganizationNov. 26, 2021Oxford/AstraZeneca
Saudi ArabiaSaudi Health CouncilDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech
ScotlandGovernment of the United KingdomDec. 4, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SenegalWorld Health OrganizationNov. 26, 2021Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
SerbiaGovernment of SerbiaDec. 3, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
SeychellesWorld Health OrganizationNov. 29, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Sierra LeoneWorld Health OrganizationNov. 26, 2021Oxford/AstraZeneca, Sinopharm/Beijing
SingaporeMinistry of HealthNov. 5, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
Sint Maarten (Dutch part)World Health OrganizationDec. 3, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SlovakiaMinistry of HealthDec. 3, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V
SloveniaNational Institute of Public Health via covid-19.sledilnik.orgDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech
Solomon IslandsSPC Public Health DivisionNov. 30, 2021Oxford/AstraZeneca
SomaliaWorld Health OrganizationNov. 13, 2021Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac
South AfricaMinistry of HealthDec. 5, 2021Johnson&Johnson, Pfizer/BioNTech
South KoreaKorea Centers for Disease Control and PreventionDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
South SudanWorld Health OrganizationNov. 23, 2021Johnson&Johnson, Oxford/AstraZeneca
SpainMinistry of HealthDec. 2, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Sri LankaMinistry of Health’s Epidemiology UnitDec. 5, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
SudanWorld Health OrganizationOct. 20, 2021Johnson&Johnson, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
SurinameGovernment of SurinameDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
SwedenPublic Health Agency of SwedenDec. 3, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
SwitzerlandFederal Office of Public HealthDec. 2, 2021Moderna, Pfizer/BioNTech
SyriaWorld Health OrganizationNov. 28, 2021Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik Light, Sputnik V
TaiwanTaiwan Centers for Disease ControlDec. 5, 2021Medigen, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
TajikistanWorld Health OrganizationNov. 28, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V
TanzaniaWorld Health OrganizationNov. 22, 2021Johnson&Johnson, Pfizer/BioNTech, Sinopharm/Beijing
ThailandGovernment of ThailandDec. 2, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac
TimorWorld Health OrganizationNov. 30, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
TogoWorld Health OrganizationNov. 26, 2021Oxford/AstraZeneca
TokelauSPC Public Health DivisionOct. 12, 2021Pfizer/BioNTech
TongaSPC Public Health DivisionNov. 30, 2021Oxford/AstraZeneca
Trinidad and TobagoMinistry of HealthDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing
TunisiaMinistry of HealthDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V
TurkeyCOVID-19 Vaccine Information PlatformDec. 5, 2021Pfizer/BioNTech, Sinovac
TurkmenistanWorld Health OrganizationAug. 29, 2021EpiVacCorona, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V
Turks and Caicos IslandsWorld Health OrganizationNov. 5, 2021Pfizer/BioNTech
TuvaluWorld Health OrganizationOct. 22, 2021Oxford/AstraZeneca
UgandaWorld Health OrganizationNov. 15, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
UkraineMinistry of HealthDec. 5, 2021Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
United Arab EmiratesNational Emergency Crisis and Disaster Management AuthorityNov. 15, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sputnik V
United KingdomGovernment of the United KingdomDec. 4, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
United StatesCenters for Disease Control and PreventionDec. 5, 2021Johnson&Johnson, Moderna, Pfizer/BioNTech
UruguayMinistry of Health via vacuna.uyDec. 5, 2021Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac
UzbekistanGovernment of UzbekistanDec. 2, 2021Moderna, Oxford/AstraZeneca, Sputnik V, ZF2001
VanuatuSPC Public Health DivisionNov. 22, 2021Oxford/AstraZeneca
VenezuelaPan American Health OrganizationNov. 29, 2021Abdala, Sinopharm/Beijing, Sinovac, Sputnik V
VietnamGovernment of VietnamDec. 3, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V
WalesGovernment of the United KingdomDec. 4, 2021Moderna, Oxford/AstraZeneca, Pfizer/BioNTech
Wallis and FutunaSPC Public Health DivisionNov. 30, 2021Moderna
YemenWorld Health OrganizationNov. 28, 2021Johnson&Johnson, Oxford/AstraZeneca, Sinovac
ZambiaGovernment of ZambiaDec. 3, 2021Johnson&Johnson, Oxford/AstraZeneca, Sinopharm/Beijing
ZimbabweMinistry of HealthDec. 5, 2021Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V

Frequently-asked questions

Why do the figures displayed on this page look different from the ones published by my government?

In some cases, the vaccination figures on this page can look different from the ones reported by a government. Most often it is not because of the numerator (number of people vaccinated) but instead because of the denominator (number of people in the population). This usually happens for two main reasons:

  1. The official data reports the vaccination coverage in terms of the share of people vaccinated in the population eligible for vaccination (very often, among adults only). Our priority is to make our data comparable between countries — regardless of criteria for eligibility, which tend to vary across countries and across time. For this reason, we always use the total population of the country (i.e. people of all ages) as the denominator.
  2. The official data uses a different population estimate. The population estimates we use come from the United Nations World Population Prospects. We use this data for its reliability, its consistent methods, and because it makes our work much easier (see below for more information). In a few cases, we use other sources when the figures provided by the UN differ substantially from reliable and more recent national estimates.
What population data are the per-capita metrics based on?

The population estimates we use come from the United Nations World Population Prospects. We use this data for its reliability, its consistent methods, and because it makes our work much easier. The exact values can be viewed in our GitHub repository.

The United Nations estimates may not always reflect the latest censuses or national figures—but there are several reasons why we use this data over country-by-country national population estimates.

  • The UNWPP dataset is the standard in research. The main reason is that it uses a reliable and standardized methodology for all countries. For example, if we used individual country data, some may include overseas workers, expats, undocumented immigrants, etc. but others wouldn’t.
  • Using data from the UN allows us to get accurate population estimates for all territories in the world very easily. Finding and maintaining estimates based on national censuses would be very time-consuming for our small team, without bringing much additional value to our work.
  • Other reasons include the availability of yearly data (national censuses are only conducted every few years), and avoiding double-counting in cases of border disputes.

For all these reasons, the UN data is the best solution to bring accurate per-capita metrics to our COVID data. In a few cases, we use other sources when the figures provided by the UN differ substantially from reliable and more recent national estimates.

Can the value of per-capita metrics exceed 100%?

The population estimates we use to calculate per-capita metrics are all based on the last revision of the United Nations World Population Prospects. In a few cases, we use other sources when the figures provided by the UN differ substantially from reliable and more recent national estimates. Additionally, it’s important to bear in mind that in some territories, vaccination coverage may include non-residents (such as tourists and foreign workers). For these reasons, per-capita metrics may sometimes exceed 100%.

What is the definition of a fully-vaccinated person?

In our data, fully-vaccinated people are those who have received all doses prescribed by their vaccination regimen (e.g. 2 doses for Pfizer/BioNTech, Moderna, Oxford/AstraZeneca, etc. and 1 dose for Johnson & Johnson, CanSino, etc.).

Some countries also allow for alternative definitions, such as having been infected with SARS-CoV-2 in the past and having received 1 dose of a two-dose regimen. We currently ignore these alternative definitions to preserve the common definition of fully vaccinated, i.e. all doses required in the vaccine regimen. This allows for an optimal comparability between countries.

What classification are the income groups based on?

The income groups we use come from the World Bank income classification. The exact list of countries can be viewed in our GitHub repository.

Why isn’t my country shown by default on a chart? How do you choose which countries are shown?

Due to the limited space on our charts and the number of countries in the world, we unfortunately cannot show every country in the world by default. On each chart of this page, we therefore choose a default selection of countries based on a mix of criteria: mainly total population, but also number of vaccine doses administered and share of the population vaccinated. These lists are updated about once a month.

In the future, we plan to develop new features that would allow the list of countries to automatically adapt to the region of each visitor, and if they allow it, to use cookies to save their default list on their computer.

How can we best estimate how many people have been vaccinated globally?

Because some countries — notably China, as of August 2021 — do not report breakdowns between first and second doses administered, we cannot know the exact number of people with at least 1 dose and people fully vaccinated in the world. The figures displayed on our charts for “World” only include data from countries that do publish this more precise information. Therefore, as long as some countries are only reporting partial data, these figures will underestimate the real number of people vaccinated and fully vaccinated globally.

Based on the number of doses administered, it is however possible to calculate a lower and upper bound of how many people have been vaccinated in these countries. For example, if 500 million doses have been used in China, they must have been administered to at least 250 million people (with 2 doses each), and up to 500 million people (with only 1 dose each).

We recommend citing the figure on our charts as the “confirmed number of people with at least 1 dose”.

A good proxy for estimating the “complete number of people with at least 1 dose” is:

My country has started vaccinating its population. Why is it missing from the charts?

Other countries that are not shown in our data may have also started vaccination campaigns. We’ll add them to our maps and charts as soon as numbers are verifiable based on public official sources. If you’re aware of an official source reporting numbers, please let us know using the “Feedback” button at the bottom of your screen.

Are participants in vaccine clinical trials included in your data?

We do not include participants in the vaccine arm of clinical trials, as this data is not available for many of the hundreds of trials currently taking place.

How do you report vaccinations performed in Israel and Palestine?

In our dataset and charts on COVID-19 vaccinations, we report vaccinations performed in Israel and Palestine separately.

The vaccination data is needed to understand how the pandemic is evolving. For this it is key to bring together the vaccination data with data on COVID-19 cases and COVID-19 deaths. Global health institutions that report on the pandemic are reporting these metrics separately: 

  • The World Health Organization reports the measures for Israel separately from Palestine in its data.
  • Johns Hopkins University also reports Israel separately from Palestine in its data on cases & deaths of COVID-19, which has been used worldwide in the last year.

Reporting the data for Palestine and Israel separately also allows us to show their respective reported vaccination levels. It makes clear what the respective vaccination levels are, as reported by the Government of Israel and the Palestinian Ministry of Health.

Finally, our dataset on COVID-19 vaccinations is sourced from official data published by governments and ministries of health from countries around the world. This is also the case for Israel and Palestine. We show figures for Palestine and Israel separately, as they are reported separately by the Government of Israel and the Palestinian Ministry of Health

The Populations Division of the United Nations reports population figures for countries around the world, and we are relying on their latest data (from their 2019 revision) for countries around the world of. They report a population of 8,655,541 people for Israel and a population of 5,101,416 people for Palestine.

The resulting shares of people vaccinated in Israel and Palestine can be seen in our COVID-19 Data Explorer.


Sign up for regular updates from Our World in Data


→ If you want to keep up-to-date with on our work on COVID-19, and the many other topics we cover you can sign up to our newsletter.